期刊文献+

龙岗区产前筛查标志物AFP、β-hCG及uE3中位数与出生缺陷的临床意义 被引量:2

Clinical significance of medians of prenatal screening markers- AFP,β- hCG and uncojugated estriol and birth defects in Longgang District
原文传递
导出
摘要 目的:建立深圳市龙岗区血清标志物AFP、β-h CG及u E3的中位数,分析其与出生缺陷的临床意义。方法:采用时间分辨荧光免疫分析仪检测7323例孕中期孕妇血清AFP、β-h CG及u E3浓度建立中位数,分析中位数调整前、后高风险检出率及风险值的差异。结果:AFP、u E3中位数值与软件内嵌值差异有统计学意义(P<0.05),但β-h CG中位数差异无统计学意义(P>0.05);中位数调整前、后高风险检出率和风险值差异无统计学意义(P>0.05)。结论:三联筛查方案中其中位数对出生缺陷风险值的影响要综合分析。 Objective: To establish the medians of serum markers - alpha fetoprotein ( AFP),β- human chorionic gonadotropin (β-hCG) and uncojugated estriol in Longgang District, analyze the clinical significance of the medians and birth defects. Methods: The concentrations of serum AFP, β- hCG and uncojugated estriol in 7 323 pregnant women during the second trimester of pregnancy were detec- ted by time - resolved fluorescence immunoassay and the medians were established. The detection rates of high risk and the differences of risk values before and after adjusting the medians were analyzed. Results: There were statistically significant differences between the medians of AFP, uncojugated estriol and software embedded values ( P 〈 0.05 ) , but there was no statistically significant difference in the median of β- hCG ( P 〉 0. 05 ) . There was no statistically significant difference in detection rates of high risk and the differences of risk values between before and after adjusting the medians ( P 〉 0. 05 ) . Conclusion : The effects of medians of AFP, β- hCG and uncojugated estriol on birth defects risk value in triple test should be comprehensively analyzed.
出处 《中国妇幼保健》 CAS 北大核心 2014年第31期5122-5124,共3页 Maternal and Child Health Care of China
基金 国家自然青年科学基金〔No:81201568〕 深圳市龙岗区卫生科技项目〔No:ys2012068〕
关键词 产前筛查 中位数 甲胎蛋白 人绒毛膜促性腺激素 游离雌三醇 出生缺陷 Prenatal screening Median Alpha fetoprotein β-human chorionic gonadotrophin Unconjugated estriol Birth de-feet
  • 相关文献

参考文献10

  • 1Huang T, Hoffman B, Meschino W, et al. Prediction of ad- verse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome [J] . Prenat Diagn, 2010, 30 (5) : 471 -477.
  • 2Wright D, Bradbury I, Malone F, et al . Cross - trimester re- peated measures testing for Downg syndrome screening: an as- sessment [J] Health Technol Assess, 2010, 14 (33) : 1 -80.
  • 3Alldred SK, Decks J J, Guo B, et al. Second trimester serum tests for Down's syndrome screening [J] . Coehrane Database Syst Rev, 2012, 6: CD009925.
  • 4Androutsopoulos G, Gkogkos P, Decavalas G. Mid - trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcome [J] -Int J Endoerinol Metab, 2013 , 1l (2) : 102 -106.
  • 5Wan X, Wen J, Song X, et al. The analysis of second - tri- mester triple screening for Down syndrome in Chinese normal singleton pregnancies [J] .Scand J Clin Lab Invest, 2012, 72 (8): 642-647.
  • 6Kaur G, Srivastav J, Sharma S, et al. Maternal serum median levels of alpha -foetoprotein, human chorionic gonadotropin & unconjugated estriol in second trimester in pregnant women from north-west India [J] . Indian J Med Res, 2013, 101 (138): 83-88.
  • 7江德洋,韩保良,李晓君.8020例孕中期母血清产前筛查结果回顾性分析[J].中国优生与遗传杂志,2013,21(2):73-74. 被引量:3
  • 8吴行飞,石鑫玮,陈馨,赵岚,崔天盆,乔福元.179例孕中期唐氏综合征筛查高风险孕妇妊娠结局的分析[J].中国优生与遗传杂志,2013,21(5):54-55. 被引量:4
  • 9Wald NJ, Cuckle HS, Densem JW, et al. Maternal serum screening for Down's syndrome in early pregnancy [J] . BMJ, 1988, 297 (6653): 883-887.
  • 10关幼华,刘世平,萧志超.5091例产前筛查结果分析及筛查标志物中位数的建立[J].国际检验医学杂志,2011,32(1):89-91. 被引量:1

二级参考文献17

共引文献5

同被引文献9

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部